glp-1 news oct 16 2025 Compound versions of drugs for weight loss halted by FDA GLP-1 Agonists Weight Loss Drugs

The roGFP1-iL and roGFP2-iL only differ in the S65T substitution introducing an additional methyl group in roGFP2

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)

Ask a healthcare professional for use beyond 4 weeks

L-Carnitine-Tartrate & Acetyl L-Carnitine are two main types of L-Carnitine

While genetic testing is not yet standard practice, researchers believe personalized obesity treatment may become more common in the future

As healthcare professionals, these guidelines challenge us to consider food-first approaches before jumping to pharmaceutical interventions